Select a medication above to begin.
Ojemda
tovorafenib
Adult Dosing .
Dosage forms: TAB: 100 mg; SUSP: 25 mg per mL
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
pediatric low-grade glioma, relapsed or refractory
- [tab form, BSA 0.9-1.12 m^2]
- Dose: 400 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation; do not cut/crush/chew tab
- [tab form, BSA 1.13-1.39 m^2]
- Dose: 500 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation; do not cut/crush/chew tab
- [tab form, BSA >1.4 m^2]
- Dose: 600 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation; do not cut/crush/chew tab
- [suspension form, BSA 0.9-1.05 m^2]
- Dose: 375 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, BSA 1.06-1.25 m^2]
- Dose: 450 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, BSA 1.26-1.39 m^2]
- Dose: 525 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, BSA >1.4 m^2]
- Dose: 600 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
renal dosing
- [see below]
- eGFR >30: no adjustment; eGFR <30: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- bilirubin 1.1-1.5x ULN or AST >ULN: no adjustment; bilirubin >1.5x ULN: not defined
Peds Dosing .
- Dosage forms: TAB: 100 mg; SUSP: 25 mg per mL
Special Note
- [uses, dosing may vary]
- Info: refer to institution protocols and pkg insert prior to prescribing for uses and dosing incl. toxicity-related dose adjustments
pediatric low-grade glioma, relapsed or refractory
- [tab form, 6 mo and older, BSA 0.9-1.12 m^2]
- Dose: 400 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation; do not cut/crush/chew tab
- [tab form, 6 mo and older, BSA 1.13-1.39 m^2]
- Dose: 500 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation; do not cut/crush/chew tab
- [tab form, 6 mo and older, BSA >1.4 m^2]
- Dose: 600 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation; do not cut/crush/chew tab
- [suspension form, 6 mo and older, BSA 0.3-0.35 m^2]
- Dose: 125 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.36-0.42 m^2]
- Dose: 150 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.43-0.48 m^2]
- Dose: 175 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.49-0.54 m^2]
- Dose: 200 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.55-0.63 m^2]
- Dose: 225 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.64-0.77 m^2]
- Dose: 275 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.78-0.83 m^2]
- Dose: 300 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.84-0.89 m^2]
- Dose: 350 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 0.9-1.05 m^2]
- Dose: 375 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 1.06-1.25 m^2]
- Dose: 450 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA 1.26-1.39 m^2]
- Dose: 525 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
- [suspension form, 6 mo and older, BSA >1.4 m^2]
- Dose: 600 mg PO qwk; Info: for pts w/ BRAF fusion or rearrangement, or BRAF V600 mutation
renal dosing
- [see below]
- eGFR >30: no adjustment; eGFR <30: not defined
- HD/PD: not defined
hepatic dosing
- [see below]
- bilirubin 1.1-1.5x ULN or AST >ULN: no adjustment; bilirubin >1.5x ULN: not defined